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Objectives The aim of the present study was to assess the efficacy of remote ischemic post-conditioning (RIPC) by repeated
intermittent balloon inflations in preventing acute kidney injury (AKI) in patients with a non–ST-segment eleva-
tion myocardial infarction undergoing percutaneous coronary intervention (PCI).
Background AKI complicating PCI is associated with increased morbidity and mortality. Remote ischemic preconditioning,
using cycles of upper limb ischemia-reperfusion as a conditioning stimulus, has been recently shown to prevent
AKI in patients undergoing elective coronary angiography.
Methods Eligible patients were randomized to receive RIPC by cycles of inflation and deflation of the stent balloon during
PCI or a sham procedure (control patients). The primary endpoint was AKI, defined as an increase of 0.5
mg/dl or 25% in serum creatinine within 96 h from PCI. The 30-day rate of death or re-hospitalization for any
cause was one of the secondary endpoints.
Results A total of 225 patients were included (median age, 68 years; 36% female). The AKI rate in the RIPC group was
12.4% versus 29.5% in the control group (p  0.002; odds ratio: 0.34; 95% confidence interval: 0.16 to 0.71). The
number needed to treat to avoid 1 case of AKI was 6 (95% confidence interval: 3.6 to 15.2). The 30-day rate of death
or re-hospitalization for any cause was 22.3% in the control group versus 12.4% in RIPC patients (p  0.05).
Conclusions RIPC by serial balloon inflations and deflations during PCI was found to confer protection against AKI in patients
with a non–ST-segment elevation myocardial infarction undergoing PCI. The reduction in the rate of AKI trans-
lated into a clear trend (of borderline significance) toward better 30-day clinical outcome. (J Am Coll Cardiol
2013;61:1949–55) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.02.023Renal dysfunction complicating percutaneous coronary in-
tervention (PCI) is associated with a marked increase in
morbidity and mortality, both in the short and long term
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2013, accepted February 25, 2013.(1,2). This is especially true for patients with acute myocar-
dial infarction treated with PCI (3). However, despite
indications that the incidence of acute kidney injury (AKI)
shows a temporal trend of decline, presumably due to
increased clinician awareness and better risk stratification
(4), well-defined measures of renoprotection, with documented
efficacy, are lacking.
The notion of remote ischemic conditioning encompasses
a group of procedures whose common denominator is
protection of an organ against tissue damage by application
of cycles of brief periods of ischemia and reperfusion in a
remote site (usually a different organ or a limb) (5–7). It was
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ischemia-reperfusion of the upper
limb (by means of a manometer cuff)
can prevent AKI in patients un-
dergoing elective coronary angiog-
raphy (8). These are very promis-
ing results, but data in other
clinically relevant patient popula-
tions, including those undergoing
PCI in the context of an acute
coronary syndrome, are needed.
The aim of the present study was
to assess the efficacy of remote isch-
emic post-conditioning (RIPC) by
repeated intermittent balloon inflations to prevent AKI in patients
with non–ST-segment elevation myocardial infarction
(NSTEMI) undergoing PCI.
Methods
Population. This was a prospective, single-blind, random-
ized, parallel-group study, conducted at 3 Greek teaching
hospitals. Patients with NSTEMI undergoing PCI within
72 h from symptom onset were included. Eligible patients
had to have at least 2 troponin I or C measurements above
the laboratory-defined 99th percentile of a normal reference
population plus 1 of the following: chest pain or electrocar-
diographic abnormalities consistent with ischemia or new
echocardiographic wall-motion abnormality. Exclusion cri-
teria were persistent ST-segment elevation (defined as lasting
20 min), left main disease, cardiogenic shock, PCI per-
formed72 h after symptom onset, on dialysis, or inability or
unwillingness to provide consent. Patients with persistent
ST-segment elevation were not included to have a more
homogeneous population (they were enrolled in a separate
study). The protocol was approved by the institutional review
boards. All patients provided informed consent.
Procedures. Patients with NSTEMI slated for cardiac
catheterization were screened for eligibility, and informed
consent was obtained. Complete review of the patient’s
history and physical examination was recorded on the
patient case report form. Pre-procedural estimated risk of
AKI (henceforth referred to as Mehran score for brevity)
was calculated according to the report by Mehran et al. (9).
Patients not undergoing PCI (e.g., no significant lesions or
referrals for surgical treatment) were not included. Eligible
patients were randomized to the RIPC treatment group or
the control group. (Randomization was done by sealed
serially numbered assignment envelopes created by an elec-
tronic random number generator and distributed to the
recruiting centers. The operator opened the corresponding
envelope before the catheterization procedure to know
whether a true or sham RIPC procedure was to be per-
formed, and the operator was the only one to know the
patient’s treatment assignment and was not involved further
Abbreviations
and Acronyms
AKI  acute kidney injury
eGFR  estimated
glomerular filtration rate
NSTEMI  non–ST-segment
elevation myocardial
infarction
PCI  percutaneous
coronary intervention
RIPC  remote ischemic
post-conditioningin any of the study procedures; unblinding was performed afterconclusion of the study procedures and database locking.) After
PCI of the presumed culprit lesion, the stent balloon was used
to perform alternating inflations and deflations (i.e., the RIPC
procedure was performed at only 1 lesion site per patient in all
patients). In the RIPC group, four 1-min cycles were per-
formed, each consisting of 30 s of inflation of the stent balloon
to the nominal pressure and 30 s of deflation. In control
patients, a sham 4-cycle RIPC procedure was performed,
whereby balloons were inflated to no more than 3 atm.
All patients received standard of care, according to
established clinical practice guidelines. The choice of ma-
terials was left to the operators, with the exception of the
radiographic contrast medium, which had to be nonionic
low osmolar. Adequate pre- and post-procedural hydration
was carefully observed whenever possible (this requisite, as
in real-life practice, could not be entirely fulfilled in the case
of patients undergoing PCI within a few hours of presen-
tation or in patients with dyspnea). The hydration plan
included normal saline solution 1 ml/kg of body weight per
hour (reduced to 0.5 mg/kg/h in patients with a left
ventricular ejection fraction of 35%) for 12 h before PCI
(whenever possible) and 24 h after the procedure. Poten-
tially nephrotoxic drugs were withheld for at least 72 h or
discontinued altogether, if possible.
Study endpoints. The primary study endpoint was AKI,
defined as an absolute increase in serum creatinine of 0.5
mg/dl or a relative increase of 25% compared with
baseline within 96 h after PCI (the maximal measured
concentration of serum creatinine during these 96 h was
used). Secondary endpoints were the relative reduction in
estimated glomerular filtration rate (eGFR), calculated with
the Modification of Diet in Renal Disease formula, within
96 h after PCI, maximum serum cystatin C change com-
pared with baseline within 96 h after PCI, as well as the
30-day rate of death or re-hospitalization for any cause.
Patients were followed by telephone contact at 15 and 30
days after the index PCI. In case of hospitalization, the
attending physicians were contacted to obtain information
regarding the cause for admission and the patient’s course.
In case of death, the certifying physician was contacted. The
personnel involved in data collection and handling were
blinded as to each patient’s randomization. Clinical end-
points were blindly adjudicated by a 3-member committee.
Statistical analysis. It was calculated that to detect a
decrease in the incidence of AKI from 30% to 15% with a
probability (power) of 0.80, at an alpha level of 0.05, 120
subjects per randomization group were needed. Analysis was
performed on an intention-to-treat basis. Continuous vari-
ables were reported as median (interquartile range) and were
compared using nonparametric tests (Mann-Whitney U and
Wilcoxon for unpaired and paired observations, respec-
tively), as most of them deviated significantly from the
normal distribution. Categorical variables were expressed as
percentages and counts and compared using the chi-square
test (or Fisher exact test if the produced matrixes contained
cells with expected count 5). Multivariate analysis of the
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performed using binary logistic regression analysis, where
continuous variables were entered as dichotomous factors
(above/below median). SPSS version 17.0 software (SPSS
Inc., Chicago, Illinois) was used. Two-sided p values0.05
were considered as indicative of statistical significance.
Results
Study flow and baseline population characteristics. A
total of 225 patients were finally included in the analysis
(median age, 68 years; 81 women). From 332 initially screened
patients, 231 were randomized, 225 of whom (113 in the
Figure 1 Study Flow Chart
Eligible patients were randomized when it was decided to proceed with percutaneo
79 patients did not undergo PCI for various reasons, unrelated to the study protoc
treatment, patient refusal). In 6 patients (3 per randomization group), the conditio
the PCI. RIC  remote ischemic post-conditioning.RIPC group and 112 in the control group) underwent true or
sham RIPC and were included in the analysis (Fig. 1). The 2
randomization groups were well balanced with similar epide-
miological background. They had equivalent pre-procedural
assessed risk for AKI, as indicated by similar Mehran score and
baseline renal function parameters. There were no significant
differences with regard to baseline medications, with a special
focus on drugs with a potential effect on renal function (Table 1).
There were also no significant differences in the procedural
aspects of the index intervention, as illustrated in Table 2.
Primary endpoint. The overall incidence of the primary
endpoint (AKI) was 21%. The AKI rate was significantly lower
ronary intervention (PCI) (among eligible patients who had provided consent,
., unsuitable lesions for PCI, decision to proceed with conservative or surgical
rocedure (true or sham) was not attempted due to technical problems related tous co
ol: e.g
ning p
and iso
C  re
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The univariate odds ratio for patients of the RIPC group
compared with the control group was 0.34 (95% confidence
interval [CI]: 0.16 to 0.71), with relative risk reduction of 58%
(95% CI: 27% to 76%). The number of patients needed to treat
to avoid 1 case of AKI was 6 (95% CI: 3.6 to 15.2).
Secondary analyses. Overall, the eGFR decreased from a
median of 75 (interquartile range: 64 to 88) ml/min/1.73 m2
to 64 (interquartile range: 49 to 85) ml/min/1.73 m2 (p 
0.001 for the difference). The median relative decrease in
eGFR was 10% (interquartile range: 0% to 23%). The
decrease in the eGFR was significantly more marked in
control patients compared with the RIPC group (Fig. 2).
Serum creatinine increased by 14.3% (interquartile range:
0.0% to 33.3%) in the control group versus 7.1% (interquar-
tile range: 0.0% to 14.3%) in the RIPC group (p  0.004).
RIPC was also associated with smaller increases in cystatin
C levels (Fig. 2).
With regard to the 30-day death or re-hospitalization rate,
25 of 112 control patients had an event (22.3%) compared with
14 of 113 patients of the RIPC group (12.4%). Almost all of
the events were re-hospitalizations (23 of 25 in the control
group and 13 of 14 in the RIPC group). The admission
diagnoses were, in the control and the RIPC group, respec-
Patient CharacteristicsTable 1 Patient Characteristics
Characteristic
O
(N 
Age, yrs 68 (6
Female 81 (3
BMI, kg/m2 27 (2
Smoking 66 (2
Hypertension 147 (6
Diabetes 82 (3
Insulin-treated diabetes 23 (1
Dyslipidemia 133 (5
Previous coronary artery disease 65 (2
Killip class III 19 (8
NYHA functional class III–IV chronic heart failure 25 (1
LVEF 0.56 (0
Mehran score 10 (2
Baseline serum creatinine, mg/dl 1.0 (0
Baseline BUN, mg/dl 21.0 (1
Baseline eGFR, ml/min/1.73 m2 75 (6
Maximum troponin I, ng/ml 2.7 (1
Maximum CK-MB, ng/ml 16.3 (1
Baseline treatment*
Beta-blocker 38 (1
ACEi/ARB 152 (6
AA 19 (8
Metformin 57 (2
Diuretic 141 (6
Statin 82 (3
Values are median (interquartile range) or count (%). *Medications recei
AA  aldosterone antagonist; ACEi  angiotensin-converting enzym
BUN  blood urea nitrogen; CK-MB  creatine kinase-myocardial b
ventricular ejection fraction; NYHA  New York Heart Association; RIPtively, acute heart failure (9 and 5), nonspecific chest pain (5and 2), persistent atrial fibrillation (3 and 2), unstable angina (2
and 1), presyncope (1 and 2), myocardial infarction (1 and 0),
stroke (1 and 0), and trauma/bone fractures (1 and 1). Al-
though the arithmetic difference in the clinical events between
the 2 groups is substantial, its statistical significance is only
borderline (p  0.047 using the uncorrected chi-square
test, whereas it becomes 0.054 if the Fisher exact test is used
[odds ratio: 0.49; 95% CI: 0.22 to 1.01]); of note, the study
was underpowered to assess clinical endpoints.
In the multivariate analysis, RIPC was an independent
negative predictor of AKI after adjusting for age, body mass
index, volume of administered contrast medium, and baseline
eGFR. The multivariate hazard ratio for patients in the RIPC
group was 0.23 (95% CI: 0.11 to 0.50; p  0.001) (Fig. 3).
Discussion
The principal finding of this prospective, randomized study
is the decrease in AKI rate associated with RIPC in patients
undergoing PCI in the context of an acute coronary syn-
drome. RIPC was implemented by intermittent inflations
and deflations of the stent balloon during PCI. The reduc-
tion in AKI was accompanied by a clear, but marginally
significant, trend toward fewer clinical events (death or
)
Controls
(n  112)
RIPC group
(n  113) p Value
68 (63–69) 68 (62–72) 0.274
42 (38) 39 (35) 0.344
27 (26–31) 27 (24–30) 0.347
37 (33) 29 (26) 0.225
75 (67) 72 (64) 0.609
38 (34) 45 (40) 0.360
10 (9) 13 (12) 0.524
69 (62) 64 (57) 0.448
36 (32) 29 (26) 0.267
9 (8) 10 (9) 0.345
11 (10) 14 (12) 0.466
.59) 0.56 (0.50–0.60) 0.57 (0.49–0.59) 0.948
10 (2–13) 10 (8–13) 0.101
) 1.1 (0.9–1.4) 1.1 (0.9–1.2) 0.198
4.7) 20.6 (16.7–26.3) 22.1 (17.2–23.6) 0.301
85 (64–91) 71 (64–88) 0.204
) 2.8 (2.0–9.4) 2.7 (1.8–9.2) 0.704
6.5) 16.4 (12.0–59.0) 16.2 (12.6–55.3) 0.684
18 (16) 20 (18) 0.635
75 (67) 77 (68) 0.906
9 (8) 10 (9) 0.833
27 (24) 30 (27) 0.399
69 (62) 72 (64) 0.667
39 (35) 43 (38) 0.615
l/within the last 3 days before the procedure.
bitor; ARB  angiotensin-receptor blocker; BMI  body mass index;
enzyme; eGFR  estimated glomerular filtration rate; LVEF  left
mote ischemic post-conditioning.verall
225
3–71)
6)
5–31)
9)
5)
6)
0)
9)
9)
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1)
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–13)
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.9–9.3
2.0–5
7)
8)
)
5)
3)
6)
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implications of decreasing AKI (which is a laboratory
endpoint) is consistent with existing evidence that renal
dysfunction associated with PCI is an important predictor
of adverse outcomes (1–3).
Remote ischemic conditioning was originally described
by Przyklenk et al. (7), who demonstrated that the applica-
tion of brief occlusions and reperfusion of the circumflex
coronary artery dramatically reduced the size of the infarct
arising from a sustained occlusion of the left anterior
descending coronary artery. An indication for the potential
of protecting the kidney through RIPC on the myocardium
in a relevant clinical setting has been provided by an
insightful study of Whittaker and Przyklenk (10), who
showed retrospectively, in 45 patients with acute myocardial
infarction undergoing PCI, that those who received 4
balloon inflations and deflations during angioplasty exhib-
ited preserved renal function, in terms of the eGFR,
compared with those who received 4 balloon inflations.
This study was retrospective and unpowered to demonstrate
differences in the rate of AKI, but its results were
hypothesis generating and are confirmed by the present
trial. Importantly, Er et al. (8) recently reported that in
patients with impaired renal function undergoing elective
coronary angiography, remote preconditioning by cycles
of limb ischemia-reperfusion (inflation and deflation of a
manometer cuff placed at the arm) leads to reduction of
AKI. The present study differs on several important
points from the study of Er et al. (8), namely, in the
Procedural DataTable 2 Procedural Data
Feature
Ove
(N 
Stent length, mm 20 (16–
Stent/balloon diameter, mm 3.00 (2.7
Intermittent inflations nominal pressure, atm N/
Infused contrast medium volume, ml 270 (240
Procedure duration, min 40 (35–
No. of implanted stents
1 138 (61.
2 66 (29.
3 21 (9.3
Type of implanted stents
Bare metal 30 (13.
Paclitaxel 41 (18.
Sirolimus/everolimus 154 (68.
Target vessel
LAD 122 (54.
LCx 36 (16.
RCA 67 (29.
Severity of CAD
Single-vessel disease 101 (44.
Multivessel disease 124 (55.
Values are median (interquartile range) or count (%).
CAD  coronary artery disease; LAD  left anterior descending art
artery; RIPC  remote ischemic post-conditioning.conditioning stimulus and procedure, the timing of cconditioning, and the patient population and clinical
setting. Patients undergoing PCI in the context of an
acute coronary syndrome represent a particularly relevant
clinical population because they are at increased risk of
renal injury compared with those undergoing elective
angiography due to various additional risk factors, includ-
ing hemodynamic instability, greater possibility of renal
microembolization, and the inability to consistently ob-
serve an adequate hydration protocol (for example, in
cases in which the patient is catheterized under emergent
or semiemergent circumstances or has dyspnea/pulmonary
congestion) (9,11–13). The present study and that by Er et al.
(8) provide evidence that 2 different RIPC modalities can be
ffective in preventing AKI; however, given the different
opulations and designs of the 2 studies, no conclusions can be
rawn on the relative effectiveness and merits of each one.
The notion of remote conditioning as a biological phe-
omenon, irrespective of its potential clinical significance, is
ell established (6,14–16). Ischemic conditioning for reno-
rotection, either local or remote, has shown evidence of
ffectiveness in various settings (16–21). However, the
ccumulated evidence should climax into demonstration of
efinitive clinical benefit if any of these ischemic condition-
ng methods are to become a part of clinical practice as an
ffective measure of renoprotection. The results of the study
y Er et al. (8) are certainly pointing in this direction, as are
he results of the present study, especially the demonstrated
orderline significant benefit in terms of reduced 30-day
Controls
(n  112)
RIPC group
(n  113) p Value
23 (17–40) 20 (16–42) 0.726
) 3.00 (2.75–3.50) 3.00 (2.75–3.50) 0.936
N/A 12 (9–12)
) 265 (250–300) 270 (240–320) 0.404
40 (35–60) 40 (35–55) 0.984
68 (60.7) 70 (61.9)
33 (29.5) 33 (29.2)
11 (9.8) 10 (8.8)
16 (14.3) 14 (12.4)
20 (17.9) 21 (18.6)
76 (67.9) 78 (69.0)
60 (53.6) 62 (54.9)
16 (14.3) 20 (17.7)
36 (32.1) 31 (27.4)
50 (44.6) 51 (45.1)
62 (55.4) 62 (54.9)
 left circumflex artery; N/A  not available; RCA  right coronaryrall
225)
40)
5–3.50
A
–310
57)
3)
3)
)
3)
2)
4)
2)
0)
8)
9)
1)linical event rate.
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tioning may appear to be something like a “spooky action at
a distance” (spukhafte Fernwirkung, a term that Einstein
used to deride quantum entanglement). However, several
experimental studies have identified a large part of the
mechanisms underlying remote conditioning, although
there remain a lot of unanswered questions. Three main
mechanisms for transmitting the protective signal from the
organ or tissue where the conditioning stimulus is applied to
the target organ have been proposed: the neuronal pathway,
the release of circulating humoral factors, and activation of
a systemic protective effect (such as an antiapoptotic or
anti-inflammatory response) (22). The neuronal pathway
Figure 2 Outcome Measures
Acute kidney injury rate and parameters of renal function in patients receiving
remote ischemic post-conditioning (RIC) and control patients. The median
decrease of eGFR in control patients was 13% (interquartile range: 0% to 30%) in
the control group versus 8% (interquartile range: 0% to 15%) in the RIC group. The
median increase of cystatin C levels was 19% (interquartile range, 8% to 26%) and
4% (interquartile range: 3% to 7%), respectively. Abbreviations as in Figure 1.involves the release of endogenous autacoids, includingneuropeptides such as calcitonin gene–related peptide (23),
adenosine (21), and bradykinin (24), from the remotely
conditioned organ to activate local afferent nerves. These in
turn stimulate efferent nerves that terminate at the remote
organ and tissue to mediate protection. Opioid, erythropoi-
etin, endocannabinoid, angiotensin I, and prostaglandin
receptors and the associated signaling pathways have been
implicated in the protective effect of remote ischemic
conditioning through humoral mechanisms (22). However,
the actual circulating humoral mediators of remote condi-
tioning remain as yet unidentified. These 2 mechanisms are
apparently in a multifaceted cross-talk with system-level
responses to the conditioning stimulus, including suppres-
sion of proinflammatory and proapoptotic genes and mod-
ulation of mitochondrial channel activity, leading to more
efficient energy management and increased resistance to
ischemia-reperfusion damage (25).
Study limitations. The present study was not designed to
provide any mechanistic insight into the potential humoral
or other mediators of remote conditioning. It would cer-
tainly be interesting to measure potential conditioning
effectors and study their associations, if any, with clinical
parameters and outcomes. Furthermore, although AKI is a
valid surrogate marker of renal damage and has been
described extensively in the literature, it is not a clinical
endpoint. The trend toward a better 30-day outcome
observed in the RIPC group, as a secondary endpoint, is of
considerable import, but does not equate to a primary
clinical outcome measure, for which a more powered study
would be necessary.
Conclusions
RIPC, using intermittent myocardial ischemia-reperfusion
cycles with serial balloon inflations and deflations, appears
to confer protection against AKI in patients with NSTEMI
undergoing PCI. The reduction in the rate of AKI trans-
lates to a clear trend toward better clinical outcome in the
30-day follow-up (lower rate of death or re-hospitalization
for any cause). Of importance, the described RIPC protocol
involves no additional materials or expenses and presents
minimal, if any, technical or logistic challenges. However,
more powered studies with longer follow-up are needed to
assert that remote ischemic conditioning can indeed lead to
clinical benefit and to compare different types of condition-
ing stimuli.
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